Pre-gestational diabetes mellitus refers to women who had either Type 1 or Type 2 diabetes before becoming pregnant. Unlike gestational diabetes, which develops during pregnancy due to placental hormones, pre-gestational diabetes means the mother enters pregnancy with established metabolic disease. Managing this condition requires careful coordination because high blood glucose levels during the earliest weeks of pregnancy can severely disrupt embryonic development.
| Feature | Type 1 Diabetes | Type 2 Diabetes |
|---|---|---|
| Primary Cause | Autoimmune destruction of pancreatic beta cells | Insulin resistance combined with relative insulin deficiency |
| Usual Onset | Childhood or young adulthood | Adulthood, though increasingly seen in younger people |
| Treatment Basis | Exogenous insulin therapy is mandatory | Lifestyle changes, oral agents, or insulin |
Both types demand rigorous blood glucose monitoring during pregnancy, but women with Type 1 face a higher risk of diabetic ketoacidosis, while those with Type 2 may have long-standing vascular changes even before conceiving.
When a pregnant woman maintains high blood glucose levels, excess glucose freely crosses the placenta to the fetus. The fetus responds by producing high amounts of its own insulin. Because insulin acts as a growth hormone in fetal life, this hyperinsulinemia drives excessive fat deposition and rapid somatic growth, leading to a large baby.
Pre-gestational diabetes increases complications for both mother and baby throughout the antenatal, intrapartum, and postnatal periods.
Optimal care for pre-gestational diabetes ideally starts before conception. Midwives and doctors encourage women to plan pregnancies so blood glucose can be tightly controlled beforehand. Baseline investigations include measuring HbA1c to assess long-term glycemic control, checking renal function with serum creatinine, and performing an ophthalmic exam to check for retinopathy. Folic acid supplementation at higher doses may be recommended to reduce neural tube defect risks.
Management centers on maintaining near-normal blood glucose levels without causing dangerous hypoglycemic episodes. Dietary counseling with a dietician ensures balanced carbohydrate intake distributed across small, frequent meals. Self-monitoring of blood glucose (SMBG) multiple times a day guides adjustments in insulin dosage. Regular antenatal visits monitor maternal blood pressure, urine protein, and fetal well-being.
As the pregnancy reaches term, planning the mode and timing of delivery is crucial. Intrapartum care involves continuous fetal heart rate monitoring and strict control of maternal blood glucose using an intravenous insulin and glucose infusion to prevent neonatal hypoglycemia at birth. Elective delivery is often planned between 38 and 39 weeks if control is good, or earlier if complications arise.
Immediately after delivery, insulin requirements drop sharply because the placenta, which produces counter-regulatory hormones, has been delivered. Women with Type 2 diabetes may temporarily revert to pre-pregnancy oral medications if not breastfeeding exclusively, while Type 1 mothers adjust their insulin doses downward. Neonates require close monitoring for hypoglycemia, respiratory distress syndrome, and jaundice.